|
Volumn 3, Issue 2, 1997, Pages 96-101
|
Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A
a a a a a |
Author keywords
Cost effectiveness; Dosage; Factor VIII; Haemophilia A; Pharmacokinetics; Prophylaxis
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
ADOLESCENT;
ADULT;
ARTICLE;
BLEEDING;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
CROSSOVER PROCEDURE;
DRUG HALF LIFE;
HEMOPHILIA A;
HUMAN;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SCHOOL CHILD;
|
EID: 0030940593
PISSN: 13518216
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2516.1997.00091.x Document Type: Article |
Times cited : (103)
|
References (9)
|